neoadjuvant

It's more accurate to the outcome in the case study, too, since treatment was locoregional and neoadjuvant only.

It looks like this trial was neoadjuvant (before treatment/ alternative to chemo and surgery), but that's not new either.

Many first-line treatments began as second/third-line or salvage treatments before experiencing line promotion or (if surgery is involved) neoadjuvant promotion.

In particular, using immunotherapies in the neoadjuvant, peri-operative setting has shown tremendous benefit in colorectal cancers.

Immunotherapy is also being trialled as a neoadjuvant with promising results.

Other novel aspect is use of neoadjuvant therapy in GBM.

I am very glad to hear that you are getting neoadjuvant chemotherapy.

You don't get neoadjuvant therapies without funding.

Some examples of why OS is limited: breast lumpectomy vs mastectomy and systemic therapy or polypectomy vs neoadjuvant therapy and colonic resection are both associated with very high morbidity that is very important to patients.

In my case I had neoadjuvant radiation followed by chemo, then surgery, capped off with more chemo to kill any cancer cells that might have tried to make a dash for it.

Neoadjuvant use of immunotherapies is established concept and is utilized in clinical practice for non-small cell lung cancer and colon cancer.